Canada· CA-DIN-02513161
MAGNESIUM SULFATE INJECTION, BP 49.3%
A magnesium sulfate product containing magnesium sulfate, registered in Canada by BAXTER CORPORATION. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Magnesium sulfate is registered in 11 of 19 countries.
Countries holding a registration under ATC B05XA05 (magnesium sulfate), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Magnesium sulfate · ATC B05XA05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- MAGNESIUM SULFATE
- Manufacturer
- BAXTER CORPORATION
- Country
- Canada (CA)
- ATC code
- B05XA05
- ATC class
- Magnesium sulfate
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
115 interactions on record for magnesium sulfate.
Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Magnesium sulfate · interactions on record
115 records
- 16 severe
- 98 moderate
- 1 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- KanamycinA07AA08severe
- NeomycinB05CA09severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Magnesium sulfate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAquaDerm Hydrous ointmentImpectron Ltd
- NetherlandsMagnesiumsulfaat Eureco-Pharma 100 mg/ml, oplossing voor injectieEureco-Pharma B.V.
- FranceSPASMAG INJECTABLE, solution injectable (IV) en ampouleGRIMBERG
- PolandInj. Magnesii Sulfurici 20% PolpharmaZakłady Farmaceutyczne POLPHARMA S.A.
- SpainSULFATO DE MAGNESIO ALTAN 150 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFGAltan Pharmaceuticals Sa
- United States50% MAGNESIUM SULFATEHF Acquisition Co. LLC, DBA Health First
- FinlandAddex-MagnesiumsulfaattiFresenius Kabi AB
- Japan硫酸マグネシウム水和物
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Denmark · Magnesiumsulfat Sad
- France · Sulfate De Magnesium Renaudin
- United Kingdom (Northern Ireland) · Magnesium Sulphate Phoenix Labs
- Greece · Magnesium Sulfate Ariti
- Ireland · Magnesium Sulfate Foran Healthcare
- Netherlands · Magnesiiumsulfaat Teva, Magnesiumsulfaat Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82c464b3-3add-473c-b31b-14adcdc17ff2 GET /v1/drugs/82c464b3-3add-473c-b31b-14adcdc17ff2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02513161",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "B05XA05",
"schedule": [
"Ethical"
],
"drug_code": "100227",
"strengths": [
"493 MG"
],
"ahfs_class": null,
"substances": [
"MAGNESIUM SULFATE"
],
"product_categorization": null
}See everything about magnesium sulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.